California State Teachers Retirement System (CalSTRS)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
5VM
MC
MB
SG
California State Teachers Retirement System (CalSTRS)'s TRDA Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Entrada Therapeutics (TRDA) stake by 74% in Q2 2026, selling an estimated $10.9K and leaving 399 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.
California State Teachers Retirement System (CalSTRS) first reported a position in TRDA in Q4 2021 and has held it in 17 quarters since. The position peaked at $280K in Q4 2024. 128 funds tracked by Wall St. Rank hold TRDA as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 399 shares of Entrada Therapeutics worth $2.94K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 1,141 Entrada Therapeutics shares in Q2 2026, an estimated $10.9K.
- Entrada Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2773 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Entrada Therapeutics in Q4 2021 and has held it in 17 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Entrada Therapeutics position peaked at $280K in Q4 2024.
- 128 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.